🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 457669307 (prev. 457669208 )
- Market Cap
- Large Cap · $2 Billion
Business: Insmed, Inc. is a biopharmaceutical company focused on patients suffering with lung diseases through the development and commercialization of targeted inhalation therapies. The Company’s lead candidate ARIKACE, is engineered to deliver anti-infective directly to the site of lung infections for at least two identified patient populations: cystic fibrosis patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections
Company Contact
- CEO
- William H. Lewis
- CFO
- Andrew T. Drechsler
- Headquarters
- 10 Finderne Avenue, Building 10, Bridgewater, , NJ 08807
- Phone
- 908-977-9900
- Investor Relations
- Blaine Davis · 908-947-2841 · blaine.davis@insmed.com